17 June 2021 - Deborah Wilkes
The US Consumer Healthcare Products Association (CHPA) has elected Johnson & Johnson’s (J&J’s) Michelle Wang Goodridge as the new chair of its board of directors. She is the industry association’s first female chair.
Goodridge started her career at J&J nearly 20 years ago in marketing and is currently president, US Self Care at J&J Consumer Health. She has been a member of the CHPA’s board of directors since 2019.
Commenting on her appointment, Goodridge said: “During the COVID-19 pandemic, self-care has become an instrumental component of healthcare and I am honoured to accept the role of CHPA board chair during an incredibly transformative time for the consumer healthcare industry.”
“I look forward to helping elevate the association’s vision – happier, healthier lives through responsible self-care,” she added. “Promoting safe use of OTC medicines, advancing dietary supplement regulatory modernisation, and continuing the CHPA’s industry-wide commitment to diversity, equity, and inclusion initiatives will be critical focus areas for me as we continue to deliver meaningful change for the industry.”
Goodridge succeeds Paul Gama, president of Procter & Gamble’s Personal Health Care business, who was elected chair in 2020 (click here to read the News story). He will continue to serve on the board as immediate past chair.
Scott Melville, CHPA president and chief executive officer, said that under Gama’s board leadership the CHPA had completed its transition into a broader association of self-care companies and launched an association-wide Diversity, Equity, and Inclusion (DE&I) initiative.
In addition to electing Goodridge as chair, the CHPA elected four new manufacturer board members – Robert Long of Bridges Consumer Healthcare, Adel Mekhail of Prestige Consumer Healthcare, Bruce Weiss of Church & Dwight, and Daniel Yim of Kobayashi Consumer Products.
Two new associate board members were elected. They are Jason Kahner of Grey Group and Stefani Klaskow of Google.